WUHAN HUAKANG CENTURY MEDICAL CO., LTD. Wuhan Huakang Century Medical Co., Ltd. Stock
Equities
301235
CNE1000057D4
Construction & Engineering
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.88 CNY | -0.61% |
|
-1.70% | -30.24% |
| Sales 2022 | 1.19B 164M 224M | Sales 2023 | 1.6B 221M 302M | Capitalization | 2.71B 373M 510M |
|---|---|---|---|---|---|
| Net income 2022 | 102M 14.05M 19.22M | Net income 2023 | 107M 14.74M 20.16M | EV / Sales 2022 | 2.64 x |
| Net cash position 2022 | 641M 88.26M 121M | Net Debt 2023 | 160M 22.08M 30.21M | EV / Sales 2023 | 1.79 x |
| P/E ratio 2022 |
36.1
x | P/E ratio 2023 |
25.1
x | Employees | 1,921 |
| Yield 2022 |
0.36% | Yield 2023 |
0.39% | Free-Float | 43.82% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.61% | ||
| 1 week | -1.70% | ||
| Current month | -6.49% | ||
| 1 month | -7.17% | ||
| 3 months | -22.60% | ||
| 6 months | -28.02% | ||
| Current year | -30.24% |
1 week
17.56
18.80
1 month
17.5119.20
Current year
14.0326.18
1 year
14.0332.92
3 years
14.0368.00
5 years
14.0368.00
10 years
14.0368.00
| Managers | Title | Age | Since |
|---|---|---|---|
Xin Qiang Xie
CEO | Chief Executive Officer | 59 | 12-03-31 |
Ying Chao Zhang
DFI | Director of Finance/CFO | 44 | 18-03-31 |
Ping Tao Tan
CHM | Chairman | 48 | 08-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ping Tao Tan
CHM | Chairman | 48 | 08-10-31 |
Xin Qiang Xie
CEO | Chief Executive Officer | 59 | 12-03-31 |
Yong Wei Tan
BRD | Director/Board Member | 43 | 14-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-21 | 17.88 | -0.61% | 478,700 |
| 24-06-20 | 17.99 | -0.88% | 929,700 |
| 24-06-19 | 18.15 | -0.11% | 345,818 |
| 24-06-18 | 18.17 | +0.66% | 343,713 |
| 24-06-17 | 18.05 | -0.77% | 381,272 |
End-of-day quote Shenzhen S.E., June 20, 2024
More quotes
Wuhan Huakang Century Medical Co Ltd is a China-based company providing comprehensive services of modern medical purification system. The Company's main products and service categories include medical purification system integration, medical equipment sales, medical consumables sales and operation and maintenance services of medical purification system. The medical purification system integration business is engaged in plane layout planning and design. The medical equipment sales business is mainly engaged in the sales of purchased medical equipment products. The medical consumables sales business is mainly engaged in the distribution of low value consumables, high value consumables and in vitro diagnostic reagents. The operation and maintenance services of medical purification system mainly include the repair, maintenance, upgrading and transformation of medical purification equipment, disinfection and sterilization of air conditioning system and others.
Sector
Construction & Engineering
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.24% | 260M | |
| -9.59% | 62.29B | |
| +0.14% | 58.11B | |
| +26.97% | 40.11B | |
| +13.93% | 31.41B | |
| +10.60% | 28.19B | |
| +14.61% | 20.73B | |
| +12.58% | 19.01B | |
| +76.98% | 17.92B | |
| +34.48% | 17.17B |
- Stock Market
- Equities
- 301235 Stock
